Novo Nordisk - The needs of people with diabetes are not only limited to adequate glycaemic control but also correspond with preventing complications. For more information read: https://www.novonordisk .co.in/patient-education/diabetes/4-pillars-of ...
![Novo Nordisk promotes new GLP-1 receptor agonist to fight diabetes, obesity < Pharma < Article - KBR Novo Nordisk promotes new GLP-1 receptor agonist to fight diabetes, obesity < Pharma < Article - KBR](http://www.koreabiomed.com/news/photo/202204/13597_14138_1024.jpg)
Novo Nordisk promotes new GLP-1 receptor agonist to fight diabetes, obesity < Pharma < Article - KBR
![Novo Nordisk på Twitter: "Things you need to know about the #diabetes pandemic #EASD2013 http://t.co/aICjXQ4Puv http://t.co/JckcLO9DGA" / Twitter Novo Nordisk på Twitter: "Things you need to know about the #diabetes pandemic #EASD2013 http://t.co/aICjXQ4Puv http://t.co/JckcLO9DGA" / Twitter](https://pbs.twimg.com/media/BUrknSWCAAAMVhh.png)